Platform Partnership Programs
Oncology & other cell/gene therapy indications
Pre-clinicalActive
Key Facts
Indication
Oncology & other cell/gene therapy indications
Phase
Pre-clinical
Status
Active
Company
About NAVAN Technologies
NAVAN Technologies is a private, pre-revenue biotech company commercializing its patented NanoStraw platform for intracellular delivery and extraction. The core technology uses physical, nanostraw conduits to transport a wide variety of cargos (DNA, mRNA, proteins) into primary cells with high efficacy and cell viability, positioning it as a potential enabler for next-generation cell and gene therapies. NAVAN is pursuing a platform business model, actively developing therapies in oncology and other areas through strategic partnerships, rather than as a standalone therapeutic developer.
View full company profile